ARPA-H picked teams to build AI agents that could adjust heart failure care, aiming for FDA authorization. Safety questions patients should ask.
ARPA-H Funds AI Agents Designed to Adjust Heart Failure Medications, Testing How Much Autonomy Patients Can Trust
by | Sep 11, 2026 | Uncategorized | 0 comments

Recent Comments